Categories: HealthcareNews

Oscar Health to Present at Upcoming Healthcare Conferences

NEW YORK–(BUSINESS WIRE)–Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced its leaders will present and provide a business update at three upcoming healthcare conferences:


  • 2024 Wells Fargo Healthcare Conference: Chief Financial Officer, Scott Blackley, will participate in a fireside chat at approximately 12:45 p.m. ET on September 4, 2024.
  • Morgan Stanley 22nd Annual Global Healthcare Conference: Chief Executive Officer, Mark Bertolini, will participate in a fireside chat at approximately 1:50 p.m. ET on September 5, 2024.
  • Baird 2024 Global Healthcare Conference: Chief Financial Officer, Scott Blackley, will participate in a fireside chat at approximately 2:35 p.m. ET on September 11, 2024.

All interested parties are invited to listen to a live webcast by visiting ir.hioscar.com and selecting the “Events & Presentations” link. Following each presentation, a webcast replay will be available on Oscar’s investor relations website for 90 days.

About Oscar Health

Oscar Health, Inc. (“Oscar”) is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. We have been challenging the status quo in the healthcare system since our founding in 2012, and are dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Our technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 1.6 million members, as of June 30, 2024.

For more information, please visit www.hioscar.com.

Contacts

INVESTOR RELATIONS:
Chris Potochar

ir@hioscar.com

MEDIA RELATIONS:
Kristen Prestano

press@hioscar.com

Staff

Recent Posts

2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement

Black Book Research Q4 flash survey shows health plans shifting from effort-based sourcing to KPI-backed…

9 hours ago

Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy

CHICAGO, IL / ACCESS Newswire / December 24, 2025 / Healthcare investors have seen this…

12 hours ago

Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon…

12 hours ago

PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

12 hours ago

MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings

Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec.…

12 hours ago